We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

New Metabolomics Biomarker for Heart Failure

Video   Apr 27, 2015

 

Yet, the clinical utility of established biomarkers is limited in particular by their lack of sensitivity for the early detection of HF. Metabolomics of plasma samples was performed by both untargeted and targeted GC-MS and LC-MS/MS. In the initial single center identification phase metabolites were nominated for multimarker panels and their performance was verified in an independent validation cohort from three clinical centers (in total >800 HF patients and >330 healthy controls). The metabolite multimarkers not only showed a similar diagnostic performance compared to NT-proBNP, but also demonstrated a significant added diagnostic value when combining with NT-proBNP for several HF subgroups. We conclude that metabolomic biomarkers may be useful in the early detection of HF. 

 
 
 
Advertisement
 

Recommended Videos

Making of Neoma MC-ICP-MS

Video

For scientists whose research requires high-precision isotope ratio data in fields of cosmo- and geochemistry, geochronology and biology, nuclear safeguards, forensics, metalomics, and provenance studies, we have created a new multicollector ICP-MS. Designed and developed in Bremen, building on the strengths of our multi-collector platform with field-proven technologies such as RPQ, 10^13 ohm Amplifier Technology and Jet Interface.

WATCH NOW

COVID, One Year Later: What Do We Know Now?

Video

ACS Reactions catch up with experts they talked to at the start of the pandemic and ask, "what do we know now that we didn’t back then?"

WATCH NOW

Detecting Psychoactive Substances in Forensic Toxicology

Video

This instalment of Teach Me in 10 features Dr Lorna Nisbet, a senior lecturer at Anglia Ruskin University. Lorna’s research interests are within the field of forensic toxicology where she specializes in the detection of new psychoactive substances that have been chemically altered to produce new types of high.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE